BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11714704)

  • 1. The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex.
    Wilkinson FH; Ahmad SS; Walsh PN
    J Biol Chem; 2002 Feb; 277(8):5734-41. PubMed ID: 11714704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residues 88-109 of factor IXa are important for assembly of the factor X activating complex.
    Wilkinson FH; London FS; Walsh PN
    J Biol Chem; 2002 Feb; 277(8):5725-33. PubMed ID: 11726655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets.
    Yang X; Chang YJ; Lin SW; Walsh PN
    J Biol Chem; 2004 Nov; 279(45):46400-5. PubMed ID: 15328360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ordered sequential mechanism for Factor IX and Factor IXa binding to platelet receptors in the assembly of the Factor X-activating complex.
    Yang X; Walsh PN
    Biochem J; 2005 Aug; 390(Pt 1):157-67. PubMed ID: 15755260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding studies of the enzyme (factor IXa) with the cofactor (factor VIIIa) in the assembly of factor-X activating complex on the activated platelet surface.
    Ahmad SS; London FS; Walsh PN
    J Thromb Haemost; 2003 Nov; 1(11):2348-55. PubMed ID: 14629468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
    Ahmad SS; Scandura JM; Walsh PN
    J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
    Wong MY; Gurr JA; Walsh PN
    Biochemistry; 1999 Jul; 38(28):8948-60. PubMed ID: 10413468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrophorin-2: a novel mixed-type reversible specific inhibitor of the intrinsic factor-X activating complex.
    Zhang Y; Ribeiro JM; Guimarães JA; Walsh PN
    Biochemistry; 1998 Jul; 37(30):10681-90. PubMed ID: 9692958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
    Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
    J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
    Jenkins PV; Dill JL; Zhou Q; Fay PJ
    Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interface between the EGF2 domain and the protease domain in blood coagulation factor IX contributes to factor VIII binding and factor X activation.
    Fribourg C; Meijer AB; Mertens K
    Biochemistry; 2006 Sep; 45(35):10777-85. PubMed ID: 16939230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles.
    Duffy EJ; Parker ET; Mutucumarana VP; Johnson AE; Lollar P
    J Biol Chem; 1992 Aug; 267(24):17006-11. PubMed ID: 1512239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.
    Ndonwi M; Broze G; Bajaj SP
    J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
    Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
    J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.
    Qureshi SH; Yang L; Rezaie AR
    Thromb Haemost; 2012 Dec; 108(6):1154-64. PubMed ID: 23014580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between residues 2228-2240 within factor VIIIa C2 domain and factor IXa Gla domain contribute to propagation of clot formation.
    Soeda T; Nogami K; Ogiwara K; Shima M
    Thromb Haemost; 2011 Nov; 106(5):893-900. PubMed ID: 21947241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the C2 domain of factor VIIIa in the assembly of factor-X activating complex on the platelet membrane.
    Ahmad SS; Walsh PN
    Biochemistry; 2005 Oct; 44(42):13858-65. PubMed ID: 16229474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
    Fang H; Zögg T; Brandstetter H
    FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis.
    Fay PJ; Beattie TL; Regan LM; O'Brien LM; Kaufman RJ
    J Biol Chem; 1996 Mar; 271(11):6027-32. PubMed ID: 8626386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
    Brandstetter H; Bauer M; Huber R; Lollar P; Bode W
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9796-800. PubMed ID: 7568220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.